Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Impact of Drug-Coated-Balloon-based Versus Drug-Eluting-Stent-based Intervention in Patients With Multivessel Coronary Artery Disease : A Prospective, Multicenter, Active-controlled, Randomized, Single-blind, Investigator-initiated Clinical Trial

NCT07539324 is registered in ClinicalTrials.gov with Genoss Co., Ltd. as lead sponsor.

NCT NCT07539324
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07539324 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Impact of Drug-Coated-Balloon-based Versus Drug-Eluting-Stent-based Intervention in Patients With Multivessel Coronary Artery Disease : A Prospective, Multicenter, Active-controlled, Randomized, Single-blind, Investigator-initiated Clinical Trial
Lead sponsor
Genoss Co., Ltd.
Phase
Not applicable
Overall status
Recruiting
Start date
September 28, 2026
Completion date
December 31, 2032
Enrollment
892 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multi vessel coronary artery disease, percutaneous coronary intervention